A recent study identifies higher serum sCD14 as an independent biomarker for the risk of porto-sinusoidal vascular disease in patients with common variable immunodeficiency (CVID). This discovery could enhance risk stratification and management strategies for affected individuals.
higher serum scd14 is an independent biomarker for porto sinusoidal vascular disease risk in cvid
Original title: “Higher serum sCD14 is an independent biomarker for porto-sinusoidal vascular disease risk in CVID.”